Search Results - "Spring, L.M."

Neoadjuvant niraparib in patients with HER2-negative, BRCA-mutated resectable breast cancer by Spring, L.M., Han, H., Hamilton, E., Irie, H., Santa-Maria, C.A., Reeves, J., Pan, P., Shan, M., Tang, Y., Graham, J.R., Hazard, S., Ellisen, L.W., Isakoff, S.J.

Get full text

Moving towards tissue-agnostic antibody drug conjugates: HER2 expression as the poster child by Abelman, R., Spring, L.M., Corcoran, R., Bardia, A.

Get full text

A Phase I Study of Adjuvant Niraparib Administered Concurrently with Postoperative Radiation Therapy in Patients with Localized Triple Negative Breast Cancer by Keenan, J.C., Dunn, S.A., Collins, M.E., Taghian, A.G., Spring, L.M., Moy, B., Bardia, A., Kuter, I., Cho, H.L., Gadd, M.A., Vidula, N., Shin, J.A., Peppercorn, J.M., Bellon, J.R., Wong, J.S., Punglia, R.S., Tolaney, S., Isakoff, S.J., Ho, A.Y.

Get full text

358TiP Phase Ib/II study of antibody-drug conjugate, sacituzumab govitecan, in combination with the PARP inhibitor, talazoparib, in metastatic triple-negative breast cancer by Bardia, A., Spring, L.M., Juric, D., Partridge, A., Ligibel, J., Kuter, I., Peppercorn, J., Parsons, H., Ryan, P., Chawla, D., Attaya, V., Fitzgerald, D.M., Viscosi, E., Lormill, B., Shellock, M., Moy, B., Tolaney, S.M., Ellisen, L.W.

Get full text

P095 - Neoadjuvant niraparib in patients with HER2-negative, BRCA-mutated resectable breast cancer by Spring, L.M., Han, H., Hamilton, E., Irie, H., Santa-Maria, C.A., Reeves, J., Pan, P., Shan, M., Tang, Y., Graham, J.R., Hazard, S., Ellisen, L.W., Isakoff, S.J.

Get full text

PCN83 Real-World Prescription Patterns of HER2+/HR- Metastatic Breast Cancer Patients after Ado-Trastuzumab Emtansine Approval: A Retrospective Cohort Study Using Electronic Health Record DATA with Cancer Registries by Ou, Z., Spring, L.M., Nohria, A., Seeger, J.D., Doucette, J., Cohen, A., Murimi-Worstell, I.B.

Get full text

PCN68 Real-World Cardiac Safety of Systemic Therapies for HER2+ Metastatic Breast Cancer in Older Versus Younger Patients: A Retrospective Cohort Study Using Electronic Health Record DATA and Cancer Registries by Ou, Z., Nohria, A., Spring, L.M., Seeger, J.D., Murimi-Worstell, I.B.

Get full text

135P Characteristics and dosing patterns of US patients diagnosed with HR+/HER2- early breast cancer initiating abemaciclib at a lower dose than the approved 150mg BID by Spring, L.M., Gathirua-Mwangi, W.G., Kim, S., Richey, M., Cui, Z.L., Whipple, S., Wang, J., Liepa, A.M., Brechtelsbauer, E., Levoir, A., Volodarsky, R., Moreira, K., Rybowski, S., Soliman, H.

Get full text